| P2093 | author name string | Bjoern B Burckhardt | |
| | Tanja Gangnus | |
| P2860 | cites work | Heart Failure in Children | Q28078446 |
| | Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. | Q32066588 |
| | Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload | Q33222138 |
| | NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies | Q33348965 |
| | Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. | Q34321508 |
| | NT-ProBNP levels in saliva and its clinical relevance to heart failure | Q34465119 |
| | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut | Q34527664 |
| | Cardiac hormones as diagnostic tools in heart failure | Q35146321 |
| | Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process | Q35614569 |
| | Natriuretic peptide metabolism, clearance and degradation | Q35831469 |
| | Role of the NT-proBNP level in the diagnosis of pediatric heart failure and investigation of novel combined diagnostic criteria | Q37231303 |
| | BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? | Q38324210 |
| | Cardiac biomarkers in pediatric heart disease: A state of art review | Q39030343 |
| | A Test in Context: Neprilysin: Function, Inhibition, and Biomarker | Q39523707 |
| | Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? | Q40116429 |
| | Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides? | Q40972748 |
| | Comparative accuracy of NT-proBNP and MR-proANP for the diagnosis of acute heart failure in dyspnoeic patients | Q41239151 |
| | Effect of posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. | Q41962588 |
| | Atrial natriuretic factor after cardiac surgery with cardiopulmonary bypass in children | Q42620848 |
| | Alpha atrial natriuretic peptide concentrations in plasma in children with congenital heart and pulmonary diseases. | Q42714154 |
| | Atrial natriuretic Peptide in young and elderly children with mild gastroenteritis | Q43101265 |
| | Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. | Q44096387 |
| | Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease | Q44642001 |
| | Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure | Q44736216 |
| | Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). | Q46078750 |
| | Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload | Q46221733 |
| | Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease | Q46627632 |
| | Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases | Q46662042 |
| | Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure | Q46904671 |
| | Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy | Q47655405 |
| | B-type natriuretic peptide levels in congenital heart disease | Q48089433 |
| | Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot | Q48140347 |
| | Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth | Q48181927 |
| | The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -. | Q48243243 |
| | Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure | Q48257128 |
| | Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice | Q48398779 |
| | Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure | Q48452821 |
| | Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect | Q48521692 |
| | Salivary B-type natriuretic peptide: a new method for heart failure diagnosis and follow-up | Q48680662 |
| | Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney | Q48708432 |
| | Diagnostic performance and reference values of novel biomarkers of paediatric heart failure | Q48715575 |
| | N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations. | Q48871174 |
| | Heart failure in children: part I: history, etiology, and pathophysiology. | Q49009412 |
| | Serum N-terminal proatrial natriuretic factor in children with congenital heart disease. | Q50991711 |
| | Atrial natriuretic peptide distribution in fetal and failed adult human hearts. | Q52250189 |
| | Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. | Q53925651 |
| | Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery | Q57312552 |
| | Presence of atrial natriuretic factor and cyclic guanosine monophosphate in saliva. Comparison of plasma and salivary concentrations during a head-down tilt | Q67494784 |
| | Atrial natriuretic factor in patients with congenital heart disease: correlation with hemodynamic variables | Q68416139 |
| | Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases | Q70020453 |
| | Plasma atrial natriuretic peptide in health and disease | Q70034308 |
| | Postural suppression of plasma atrial natriuretic polypeptide concentrations in man | Q70039591 |
| | Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor | Q70044729 |
| | [Methodological problems in the radioimmunologic measurement of ANP (atrial natriuretic peptide)] | Q70059498 |
| | Plasma and right auricle concentrations of atrial natriuretic polypeptide in children with cardiac diseases | Q70059835 |
| | Determinants of plasma atrial natriuretic factor concentrations in congenital heart disease | Q70061310 |
| | Plasma atrial natriuretic peptide in patients with congenital heart diseases | Q70062175 |
| | Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age | Q73806505 |
| | Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma | Q74557947 |
| | Interventional catheterization decreases plasma levels of atrial natriuretic peptide (ANP) in children with congenital heart defects | Q77296045 |
| | Plasma atrial natriuretic peptide in fetuses with cardiac disease | Q81093587 |
| | Plasma levels of natriuretic peptide type B and A in children with heart disease with different types of cardiac load or systolic dysfunction | Q81268303 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sacubitril | Q17811448 |
| | biomarker | Q864574 |
| P304 | page(s) | 420 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in pediatrics | Q27725038 |
| P1476 | title | Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure-A Comparative Review | |
| P478 | volume | 6 | |